Labcorp Holdings (LH) achieved significant margin improvement in FY 2025, with revenue reaching US$3,515.8 million in Q4 and trailing twelve-month EPS at US$10.53, leading to a 6.3% net profit margin. This rebound in earnings follows a five-year decline, fueling a bullish narrative supported by new tests, efficiency gains, and recent acquisitions. However, skeptics point to a P/E ratio above the industry average, a high debt load, and modest revenue growth, suggesting execution risk remains.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Labcorp Holdings (LH) Margin Improvement Reinforces Bullish Earnings Recovery Narrative
Labcorp Holdings (LH) achieved significant margin improvement in FY 2025, with revenue reaching US$3,515.8 million in Q4 and trailing twelve-month EPS at US$10.53, leading to a 6.3% net profit margin. This rebound in earnings follows a five-year decline, fueling a bullish narrative supported by new tests, efficiency gains, and recent acquisitions. However, skeptics point to a P/E ratio above the industry average, a high debt load, and modest revenue growth, suggesting execution risk remains.